10-K: Tradewinds Universal Reports Fiscal Year 2024 Results, Focuses on Sustainable Protein and Pet Health

Sentiment:

Annual Results


Tradewinds Universal's 10-K filing reveals a year of revenue growth driven by protein bar sales, licensing rights, and affiliate marketing, alongside ongoing efforts to expand its product line and explore green business opportunities.

Capital raiseThe company anticipates raising capital through revenues from licensing rights sales or through some form of debt or equity financing.Currently, the company has no arrangements for any funding sources.
Worse than expectedThe company's cash position has significantly deteriorated, raising concerns about its ability to fund operations.The company's auditor has raised substantial doubt about the company's ability to continue as a going concern.

Summary

  • Tradewinds Universal, incorporated in Wyoming on December 28, 2021, focuses on developing and distributing nutrient-based edible insect foods under the brand 'Universal Protein (UP)'.
  • The company's product line includes protein bars, shakes, and other nutritional foods, with a secondary focus on dog treats designed to alleviate pain.
  • In 2024, Tradewinds Universal generated $171,596 in revenue, an increase from $145,085 in 2023, driven by affiliate marketing commissions, licensing rights for a dog pain relief formula, and sales of UP protein bars.
  • The company sold its entire inventory of protein bars and is currently assessing market reception and evaluating potential business models.
  • The company is exploring new copackers to secure more competitive pricing and is in the process of developing a third SKU to further expand its protein bar offerings.
  • Operating expenses for 2024 were $219,323, including professional fees, marketing fees, and amortization, compared to $362,683 in 2023.
  • The company reported a net loss of $115,743 for 2024, compared to a net loss of $182,191 for 2023.
  • As of December 31, 2024, the company had cash and cash equivalents of $210.
  • The company is exploring opportunities in the green business sector, but no definitive plans have been established.
  • The company plans to expand its affiliate commission program and promote licensing rights for its dog pain relief formula.
  • The company anticipates raising capital through revenues from licensing rights sales or through some form of debt or equity financing.

Sentiment

Score: 4

Explanation: While revenue increased and net loss decreased, the company's limited cash reserves and reliance on external funding raise concerns about its financial stability and future prospects. The auditor's going concern warning further contributes to a negative sentiment.

Positives

  • Revenue increased in 2024 due to diversified income streams: protein bar sales, licensing rights, and affiliate marketing.
  • The company successfully sold exclusive licensing rights for its dog pain relief formula in Mexico, demonstrating market interest in its products.
  • The company is actively exploring opportunities in the green business sector, aligning with growing consumer demand for sustainable products.
  • The company's net loss decreased in 2024, indicating improved financial performance.
  • The company is assessing market reception and evaluating potential business models for its protein bars, which could lead to more efficient operations.
  • The company is in the process of creating a third SKU to further expand its protein bar offerings, potentially increasing sales and market share.

Negatives

  • The company reported a net loss of $115,743 for 2024, indicating that expenses still exceed revenue.
  • As of December 31, 2024, the company had very limited cash and cash equivalents of $210, raising concerns about short-term liquidity.
  • The company has not resumed the manufacturing or sale of its protein bars, indicating potential challenges in production or market demand.
  • The company acknowledges that there is no guarantee that licensing rights, products, and affiliate commission income will be sufficient to support its operational plan.
  • The company anticipates raising capital through revenues from licensing rights sales or through some form of debt or equity financing, indicating a reliance on external funding.

Risks

  • The company has a limited operating history in an evolving industry, making it difficult to evaluate future prospects.
  • The company's ability to generate positive cash flow is uncertain, and failure to do so could force the company to suspend or discontinue operations.
  • The company will require additional capital to support business growth, and this capital might not be available on acceptable terms.
  • There is currently no public market for the company's common stock, which could negatively affect the value of the stock and make it difficult to sell shares.
  • If the company fails to maintain an effective system of internal controls, it may not be able to accurately report its financial results or prevent fraud.
  • The company plans to be quoted on the OTC QB marketplace instead of a national securities exchange, which may result in significant volatility in the market price of the stock.
  • The company has not paid dividends in the past and has no immediate plans to pay cash dividends.
  • Shares eligible for future sale may adversely affect the market for the company's common stock.
  • The company's charter documents and Wyoming law may inhibit a takeover that stockholders consider favorable.
  • Penny stock regulations may impose certain restrictions on marketability of the company's securities.
  • FINRA sales practice requirements may limit a stockholder's ability to buy and sell the company's stock.
  • The company's auditor has raised substantial doubt about the company's ability to continue as a going concern.

Future Outlook

The company expects operating expenses to increase as it develops additional product lines and establishes a market for its current product line. The company also expects to incur additional operating expenses as it begins operating as a public company. The company anticipates raising capital through revenues from licensing rights sales or through some form of debt or equity financing.

Management Comments

  • The company plans to expand its affiliate commission program to enhance market reach and sales performance.
  • The company is actively exploring opportunities in the green business sector.
  • The company anticipates raising capital through revenues from licensing rights sales or through some form of debt or equity financing.

Industry Context

The Global Edible Insects Market was estimated to reach $1.8 billion in 2025. The edible insect market is expected to grow at a CAGR of 26.5% from 2020 to 2027, reaching $4.63 billion by 2027. Consumers are showing increased interest in alternative protein sources beyond traditional beef, pork, and chicken. According to Barclays, the edible insect industry could be worth $8 billion by 2030, up from under $1 billion last year.

Comparison to Industry Standards

  • Aspire Food Group, a competitor in the edible insect market, has raised $21.6 million in funding, according to Crunchbase data.
  • Aspire has established a production facility in Ontario, Canada, capable of producing 20,000 metric tons of food-grade cricket protein and frass per year.
  • The plant-based meat market generated revenue of $4.2 billion globally in 2018, driven primarily by companies such as Impossible Foods and Beyond Meat.
  • According to Grand View Research, the global insect protein market was worth $250 million in 2020 and is projected to grow at a CAGR of 27.4% from 2021 to 2028.

Stakeholder Impact

  • Shareholders may experience dilution if the company raises capital through equity financing.
  • Employees' job security may be at risk if the company is unable to secure sufficient funding.
  • Customers may benefit from the company's focus on sustainable and health-conscious products.
  • Suppliers may benefit from increased demand for ingredients if the company expands its product line.
  • Creditors may face increased risk if the company's financial condition deteriorates.

Next Steps

  • The company plans to expand its affiliate commission program.
  • The company plans to promote licensing rights for its pain relief formula for dogs.
  • The company expects to finalize one more new SKU for a bar by the end of 2025.
  • The company is assessing market reception and evaluating potential business models for its protein bars.
  • The company is exploring new copackers to secure more competitive pricing.
  • The company is in the process of creating a third SKU to further expand its protein bar offerings.

Key Dates

DateDescription
2021-12-21Tradewinds Universal was established in Wyoming.
2022-12-07The Company acquired a proprietary formula for natural pain relief for animals from BearCreek Resources, Corp.
2022-12-11Tradewinds acquired a pain relief formula for dogs, which it plans to produce and distribute as treats, as well as offer licensing rights for the formula.
2023-12-04Manufacturing and packaging of the two formulated SKUs were completed and shipped.
2023-12-28Andrew Read was issued 22,000,000 shares for services per an amended employment agreement.
2024-04The company entered into a purchase agreement with a smaller distributor for 1,040 cases of UP bars containing 12,480 bars for $24,960.
2024-12-31All bars in inventory had been sold.
2025-03-31Date of the 10-K filing.

Keywords

protein bars, edible insects, dog pain relief, licensing rights, affiliate marketing, green business, UP Proteins, Tradewinds Universal, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.